| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.1 |